Accueil › Cancers gastro-intestinaux › Massachusetts › Boston
Essais cliniques pour Cancers gastro-intestinaux à Boston, MA
15 études pour Cancers gastro-intestinaux recherchent des participants dans et autour de Boston (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Recrutement en coursPhase 1
- Dana-Farber Cancer Institute, Boston
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Recrutement en coursPhase 3
- GSK Investigational Site, Boston
- GSK Investigational Site, Boston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Recrutement en coursPhase 2
- Dana-Farber Cancer Institute - Oncology Department, Boston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Recrutement en coursPhase 3
- Brigham and Women's Hospital (BWH), Boston
- Dana-Farber Cancer Institute (DFCI), Boston
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Recrutement en coursPhase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Recrutement en coursPhase 1/2
- Dana Farber Cancer Institute, Boston
SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Recrutement en cours
- Dana Farber Cancer Institute, Boston
Resilience and Equity in Aging, Cancer, and Health (REACH)
Recrutement en cours
- Dana-Farber Cancer Institute, Boston
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Recrutement en coursPhase 2
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Massachusetts General Hospital Cancer Center, Boston
BOLSTER: Learning New Skills to Thrive
Recrutement en cours
- Dana-Farber Cancer Institute, Boston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Recrutement en coursPhase 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Recrutement en coursPhase 1/2
- Massachusetts General Hospital,, Boston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Recrutement en coursPhase 1/2
- Dana Farber Cancer Institute, Boston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Recrutement en coursPhase 1/2
- Massachusetts General Hospital, Boston
Essais pour Cancers gastro-intestinaux dans d'autres villes
- Houston, TX21 études
- New York City, NY12 études
- Nashville, TN10 études
- Los Angeles, CA9 études
- Dallas, TX8 études
- Cincinnati, OH8 études
- Durham, NC8 études
- Arlington, VA8 études
- Baltimore, MD8 études
- Baldwin Park, CA7 études
- Seattle, WA7 études
- San Antonio, TX7 études
Autres études à Boston
- Cancer du sein112 études
- Cancer du poumon non à petites cellules90 études
- Cancer (tous types)85 études
- Cancer métastatique63 études
- Cancer colorectal63 études
- Cancer du poumon62 études
- Cancer de l'ovaire61 études
- Cancer de la prostate59 études
- Dépression52 études
- Cancer de l'endomètre50 études
- Insuffisance cardiaque44 études
- Leucémie aiguë myéloïde44 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.